Breaking News India

Patanjali’s license is at risk

Patanjali Ayurved Ltd. faces the risk of losing the license granted for its new Coronil drug, which the company claims to be an effective cure for Covid-19. The business sponsored by Baba Ramdev did not state, that it was producing a medication for Covid-19 while applying for the license, according to the Uttrakhand Ayurveda Department. The authority is planning to issue a notice to Patanjali and if the company fails to provide a statisfactory response to the authority, then the license will be cancelled.

YS Rawat, the joint director of Uttarakhand Ayurveda Department’s licensing authority said that, “We did not issue any license to the company for developing a medicine for Covid-19. Patanjali applied for a license for immunity booster kits only. If we don’t get a satisfactory response them, then their license will be cancelled soon.”

Patanjali launched a Corona Kit with the Coronil and Swasari medicines on Tuesday, with Baba Ramdev claiming 100 per cent positive outcomes during trials. Hours after launching the kit, the ministry of Union AYUSH asked Patanjali not to advertise it. AYUSH minister Shripad Naik said on Wednesday that Patanjali was a “good initiative” to come with the medicine but had to be followed due to process.

Officials said they are currently investigating if there were any breaches in th claims. “Based on our investigation, we’re going to give them a notice asking for specifics of how they received permits to make the package,” Rawat said. As asked, the state government had sent all the documentation related to granting the license to Patanjali to the AYUSH ministry. Ramdev explained that the ministry had sent all the documents needed. “There has been some miscommunication throughout the entire process. We have followed all the procedures. Documents sought by AYUSH’s Union Ministry have already been submitted,” as he stated.

Trouble is also being mounted for Patanjali and NIMS Hospital in Japur, which reportedly collaborated with the Patanjali Research Institute for the medicine’s clinical trials. The department of State Health has called the clinical trials illegal and served hospital notice. The Chief Medical and Health Officer of Jaipur Dr Narottam Sharma claimed that Patanjali or NIms had not sought or obtained official permission for the so-called trials.

Related posts

Results of 12th declared : Haryana Board

TAC Delhi

E-filing of Income Tax

TAC Delhi

Rafale: A game-changing strategy

The Asian Chronicle

International Women’s Day Special: A journey hard struggle to big success

The Asian Chronicle

DEPWD organises ‘Global IT Challenge for Youth with Disabilities, 2018’from 9th to 11th November, 2018

theasianchronicle

UNPRECEDENTED ECONOMIC RECESSION IS ALARMING IN INDIA

TAC Delhi

Leave a Comment